March Newsmakers

March 14, 2019
By: Julie Poucher Harbin, Writer, DCI

The Duke Basketball Phenom Who Now Takes Shots At Cancer (WUNC)
Features Georgia Beasley, MD

Pancreatic cancer survivor has message of hope for Alex Trebek (WTVD)
Features DCI patient and Kevin Shah, MD (Duke Raleigh)

ASCO Honors Leaders in Cancer Care With 2019 Special Awards (ASCO press release)
Features Arif Kamal, MD, MBA, MHS, FAAHPM and Yousuf Zafar, MD, MHS

Glioma Status Monitored Using Liquid CSF Biopsy, DNA Sequencing (Neurology Today)
Features Hai Yan, MD, PhD, and Bill Diplas, MD-PhD candidate

Dr. George on Dosing TKIs in RCC (OncLive)
Features Daniel George, MD

Novel Agents Offer Hope in Hepatocellular Carcinoma (OncLive)
Features Michael Morse, MD

WATCH: Dr. Armstrong Discusses ARCHES Trial in Prostate Cancer (OncLive)
Features Andrew Armstrong, MD

Blood Test Study Meets Goal, Validates Epic’s Prostate Cancer Target (Exome)
Features Andrew Armstrong, MD

Dr. Mettu on the Potential of CPI-613 in Metastatic Pancreatic Cancer (OncLive)
Features Niharika Mettu, MD

Emerging Agents May Fill Therapeutic Gap in Metastatic Pancreatic Cancer (OncLive)
Features Niharika Mettu, MD

PRRT Moves Needle Forward in NETs, But Unmet Needs Remain (OncLive)
Features Michael Morse, MD

Strickler Stresses Continued Focus on Molecular Subtypes in mCRC (OncLive)
Features John Strickler, MD

Dr. Strickler on Therapies for Rare Variants of Relapsed/Refractory CRC (OncLive)
Features John Strickler, MD

Key Trials Show Utility of Agents Across Therapeutic Classes in Gastric/GEJ Cancer (OncLive)
Features Hope Uronis, MD

Trial: Improved Survival for Patients with Metastatic Prostate Cancer (Specialty Pharmacy Times)
Features Andrew Armstrong, MD

Key to rare aggressive liver cancer found in RNA molecule (Cornell Chronicle)
Features Mark Jewell, PhD

Patients With mCRPC May Have Reduced Skeletal Events With Layered Radium-223/Abiraterone (Targeted Oncology)
Features Daniel George, MD

Duke University School of Medicine Again Ranked Among Country’s Top Medical Schools (Duke University SoM

Precision health initiative brings genetic testing to Veterans (VA Press Release)
According to Duke SoM, Deepak Voora, MD, will direct the new Pharmacogenomics Action for Cancer Survivorship Program

How I treat refractory chronic graft-versus-host disease. Blood. 2019. Stefanie Sarantopoulos, Adela R. Cardones and Keith M. Sullivan.

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study. Journal of Clinical Oncology. March 13, 2019. Andrew J. Armstrong, MD; Susan Halabi, PhD; Jun Luo, PhD; David M. Nanus, MD; Paraskevi Giannakakou, PhD; Russell Z. Szmulewitz, MD; Daniel C. Danila, MD; Patrick Healy, MS; Monika Anand, PhD; Colin J. Rothwell, BA; Julia Rasmussen, MS; Blair Thornburg, CNA; William R. Berry, MD; Rhonda S. Wilder, MS; Changxue Lu, PhD; Yan Chen, PhD; John L. Silberstein, MHS; Gabor Kemeny, MS; Giuseppe Galletti, MD, PhD; Jason A. Somarelli, PhD; Santosh Gupta, PhD; Simon G. Gregory, PhD; Howard I. Scher, MD; Ryan Dittamore, MBA; Scott T. Tagawa, MD; Emmanuel S. Antonarakis, MD; and Daniel J. George, MD.

Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNAActa Neuropathologica.  February 2019. Pan, C; Diplas, BH; Chen, X; Wu,Y; Xiao, X; Jiang, L; Geng, Y; Xu, C; Sun, Y; Zhang, P; Wu, W; Wang, Y; Wu, Z; Zhang, J; Jiao, Y; Yan, H; Zhang, L.